首页> 外文期刊>眼视光学杂志(英文版) >Comparison between toric and spherical phakic intraocular lenses combined with astigmatic keratotomy for high myopic astigmatism
【24h】

Comparison between toric and spherical phakic intraocular lenses combined with astigmatic keratotomy for high myopic astigmatism

机译:复曲面和球形晶状体人工晶状体联合散光角膜切开术治疗高度近视散光的比较

获取原文
获取原文并翻译 | 示例
       

摘要

Background: To compare the outcomes of a toric phakic intraocular lens (PIOL) and a spherical PIOL combined with astigmatic keratotomy (AK) for the correction of high myopic astigmatism. Methods: This study enrolled patients with high myopic astigmatism, including 30 eyes (22 patients) that received a toric PIOL implantation (TCL group), and 32 eyes (24 patients) that received combined AK and a spherical PIOL implantation (AK+ ICL group). The outcomes were compared between the two groups before surgery, and at the following time points after surgery: 1 week, 1, 3, 6 months, and 1, 2 years. Results: Preoperatively, the mean manifest spherical equivalent (SE) was -14. 14 ± 2. 12 D in the TICL group and -14. 83 ± 2. 79 D in the AK + ICL group (P = 0. 28), and the mean manifest refractive cylinder, -2. 87 ± 1. 09 D and -2. 58±0. 85 D, respectively (P = 0. 28). Two years postoperatively, the mean safety index was 1. 53±0. 55 in the TICL group and 1. 60 ± 0. 70 in the AK + ICL group (P = 1. 00), and the mean efficacy index, 1. 18 ± 0. 45 and 1. 38±0. 52, respectively (P = 0. 86). The mean manifest refractive cylinder correction was 1. 94±1. 07 D in the TICL group and 1. 39±0. 71 D in the AK + ICL group (P = 0. 02). The mean changes in SE and refractive cylinder from 1 week to 2 years were less than 0. 50 D in both groups. Conclusions: Both TICL implantation and AK + ICL implantation are a good alternative for correction of astigmatism in addition to high myopia. TICL implantation has better predictability in correction of high myopic astigmatism. Trial registration: NCT03202485
机译:背景:为了比较复曲面有晶状体人工晶状体(PIOL)和球形PIOL结合散光角膜切开术(AK)矫正高度近视散光的效果。方法:本研究招募了高度近视散光的患者,其中包括30眼(22例)接受了复曲面PIOL植入(TCL组)和32眼(24例)接受了联合AK和球形PIOL植入(AK + ICL组) 。在手术前和手术后以下时间点比较两组的结果:1周,1、3、6个月和1、2年。结果:术前平均表现球当量(SE)为-14。 TICL组为14±2。12D,-14。在AK + ICL组中为83±2。D(P = 0. 28),平均明显屈光柱为-2。 87±1. 09 D和-2。 58±0。 85 D(P = 0. 28)。术后两年的平均安全指数为1. 53±0。 TICL组为55,而AK + ICL组为1. 60±0。70(P = 1. 00),平均功效指数为1. 18±0. 45和1. 38±0。 52(P = 0. 86)。平均明显屈光柱面矫正为1. 94±1。 TICL组为07 D,1为39±0。 AK + ICL组中的71 D(P = 0. 02)。两组SE和屈光柱从1周到2年的平均变化均小于0. 50D。结论:除了高度近视以外,TICL植入和AK + ICL植入都是矫正散光的好选择。 TICL植入在矫正高度近视散光方面具有更好的可预测性。试用注册:NCT03202485

著录项

  • 来源
    《眼视光学杂志(英文版)》 |2018年第3期|19-25|共7页
  • 作者单位

    The Eye Hospital of Wenzhou Medical University, 270 Xueyuan West Road, Wenzhou 325000, Zhejiang, People's Republic of China;

    The Eye Hospital of Wenzhou Medical University, 270 Xueyuan West Road, Wenzhou 325000, Zhejiang, People's Republic of China;

    The Eye Hospital of Wenzhou Medical University, 270 Xueyuan West Road, Wenzhou 325000, Zhejiang, People's Republic of China;

    The Eye Hospital of Wenzhou Medical University, 270 Xueyuan West Road, Wenzhou 325000, Zhejiang, People's Republic of China;

    The Eye Hospital of Wenzhou Medical University, 270 Xueyuan West Road, Wenzhou 325000, Zhejiang, People's Republic of China;

    The Eye Hospital of Wenzhou Medical University, 270 Xueyuan West Road, Wenzhou 325000, Zhejiang, People's Republic of China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:58:36
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号